Our Story
Centerline Biomedical was born out of a collaboration between science and medicine.
Vikash Goel, our Founder and CTO, studied under Professor Don Greenberg, a leading expert in Computer Graphics, at Cornell University. Don Greenberg introduced Vikash to his son Dr. Roy Greenberg – one of the pioneers of complex aortic repair at the Cleveland Clinic. Roy invited Vikash to work with him, and they spent the next 10 years working on the IOPS® technology. Unfortunately, Roy passed away several years ago due to cancer, and many feel that fluoroscopic radiation was to blame.
Vikash and his team have forged on in Roy’s memory to complete what he had begun – mitigate radiation exposure and advance navigation imaging to improve outcomes and protect both patient and caregiver.
Centerline Biomedical was born out of a collaboration between science and medicine.
Vikash Goel, our Founder and CTO, studied under Professor Don Greenberg, a leading expert in Computer Graphics, at Cornell University. Don Greenberg introduced Vikash to his son Dr. Roy Greenberg – one of the pioneers of complex aortic repair at the Cleveland Clinic. Roy invited Vikash to work with him, and they spent the next 10 years working on the IOPS® technology. Unfortunately, Roy passed away several years ago due to cancer, and many feel that fluoroscopic radiation was to blame.
Vikash and his team have forged on in Roy’s memory to complete what he had begun – mitigate radiation exposure and advance navigation imaging to improve outcomes and protect both patient and caregiver.
2014
Company Founded
- Cleveland Clinic spun out Centerline Biomedical as a stand alone company, housed in Cleveland Clinic’s Global Cardiovascular Innovations Center.
2016
First Preclinical Study
- Led by Dr. Matthew Eagleton on May 2nd 2016, this study verified the ability to use the navigation system in manipulating through the aorta and its branches in the absence of radiation-inducing fluoroscopy
2018
Awarded First of Two NIH Phase I Small Business Grants
- In February of 2018 Centerline was awarded an NIH / STTR phase I grant to harness the HoloLens® AR technology for aortic aneurysm repair surgery and in August of 2018 they were awarded another NIH grant focusing on applying the IOPS technology to heart valve replacement, coupled with further developing the augmented reality (AR) technology.
2019
FDA 510(k) Clearance Achieved
- In June of 2019, Centerline Biomedical received 510(k) clearance from the United States Food and Drug Administration (FDA) to market its flagship product, the Intra-Operative Positioning System, IOPS
2020
First Human Use & Controlled Launch in USA
- In April of 2020, Dr. Behzad Farivar completed the first in a series of clinical cases in the United States at the Cleveland Clinic.
2022
Series B Funding
- Raised $33M in Series B funding to propel the company into new surgical applications, accelerate its commercial sales and add to its growing clinical evidence repository.